B-Group
AI_NATIVE detailed information: This accession holds the following tickers:[ "AKRO", "INSM", "ADMA", "CLLS", "TSHA", "ASMB", "SYRE", "APGE", "SGHT", null, "IOVA", null, "AURA", "PRAX", "ETNB", "ZLAB", "ORKA", "RARE", "BNTX" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 19
- Total Value
- 116734593
- Accession Number
- 0001420506-25-001152
- Form Type
- 13F-HR
- CIK
- b-group
- Manager Name
- B-Group
Data Enrichment
89% identified17 identified2 unidentified
Holdings
19 positions • $116.7M total value
Manager:
Search and click to pin securities to the top
Shares:1.5M
Value:$5.0M
% of Portfolio:4.3% ($5.0M/$116.7M)
Shares:47.5K
Value:$1.7M
% of Portfolio:1.5% ($1.7M/$116.7M)
90400D908
Shares:37.6K
Value:$1.4M
% of Portfolio:1.2% ($1.4M/$116.7M)
Shares:19.0K
Value:$719.5K
% of Portfolio:0.6% ($719.5K/$116.7M)
Shares:58.2K
Value:$597.3K
% of Portfolio:0.5% ($597.3K/$116.7M)
221015950
Shares:90.0K
Value:$286.2K
% of Portfolio:0.2% ($286.2K/$116.7M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
2.3M | YoY- | All Managers (Combined) | $46.0M | 39.4% ($46.0M/$116.7M) | YoY- | |
INSMED Inc(INSMcusip457669307) | 262.5K | YoY- | All Managers (Combined) | $20.0M | 17.2% ($20.0M/$116.7M) | YoY- |
Zai Lab Ltd(ZLABcusip98887Q104) | 400.0K | QoQ 0.00% (+0)YoY- | All Managers (Combined) | $14.5M | 12.4% ($14.5M/$116.7M) | YoY- |
242.5K | YoY- | All Managers (Combined) | $9.8M | 8.4% ($9.8M/$116.7M) | YoY- | |
1.5M | YoY- | All Managers (Combined) | $5.0M | 4.3% ($5.0M/$116.7M) | YoY- | |
Cellectis S.A.(CLLScusip15117K103) | 3.3M | YoY- | All Managers (Combined) | $4.0M | 3.5% ($4.0M/$116.7M) | YoY- |
472.6K | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $2.8M | 2.4% ($2.8M/$116.7M) | YoY- | |
833.6K | YoY- | All Managers (Combined) | $2.0M | 1.7% ($2.0M/$116.7M) | YoY- | |
200.0K | YoY- | All Managers (Combined) | $1.9M | 1.6% ($1.9M/$116.7M) | YoY- | |
1.3M | YoY- | All Managers (Combined) | $1.7M | 1.5% ($1.7M/$116.7M) | YoY- | |
47.5K | YoY- | All Managers (Combined) | $1.7M | 1.5% ($1.7M/$116.7M) | YoY- | |
BioNTech SE(BNTXcusip09075V102) | 15.0K | YoY- | All Managers (Combined) | $1.4M | 1.2% ($1.4M/$116.7M) | YoY- |
(cusip90400D908)✕ | 37.6K | YoY- | All Managers (Combined) | $1.4M | 1.2% ($1.4M/$116.7M) | YoY- |
70.0K | YoY- | All Managers (Combined) | $1.1M | 1.0% ($1.1M/$116.7M) | YoY- | |
30.0K | YoY- | All Managers (Combined) | $1.1M | 1.0% ($1.1M/$116.7M) | YoY- | |
19.0K | QoQ NEW(+19.0K) YoY- | All Managers (Combined) | $719.5K | 0.6% ($719.5K/$116.7M) | QoQ NEW(+$719.5K) YoY- | |
89bio, Inc.(ETNBcusip282559103) | 95.6K | QoQ NEW(+95.6K) YoY- | All Managers (Combined) | $695.2K | 0.6% ($695.2K/$116.7M) | QoQ NEW(+$695.2K) YoY- |
58.2K | YoY- | All Managers (Combined) | $597.3K | 0.5% ($597.3K/$116.7M) | YoY- | |
(cusip221015950)✕ | 90.0K | YoY- | All Managers (Combined) | $286.2K | 0.2% ($286.2K/$116.7M) | YoY- |